These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34752422)

  • 1. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease.
    Arinze NV; Yin W; Lotfollahzadeh S; Napoleon MA; Richards S; Walker JA; Belghasem M; Ravid JD; Hassan Kamel M; Whelan SA; Lee N; Siracuse JJ; Anderson S; Farber A; Sherr D; Francis J; Hamburg NM; Rahimi N; Chitalia VC
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34752422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tryptophan-derived uremic metabolite/Ahr/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease.
    Thome T; Vugman NA; Stone LE; Wimberly K; Scali ST; Ryan TE
    JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38652558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans.
    Kolachalama VB; Shashar M; Alousi F; Shivanna S; Rijal K; Belghasem ME; Walker J; Matsuura S; Chang GH; Gibson CM; Dember LM; Francis JM; Ravid K; Chitalia VC
    J Am Soc Nephrol; 2018 Mar; 29(3):1063-1072. PubMed ID: 29343519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway.
    Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan Metabolites Regulate Neuropentraxin 1 Expression in Endothelial Cells.
    Vial R; Poitevin S; McKay N; Burtey S; Cerini C
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the aryl hydrocarbon receptor in endothelial cells improves ischemic angiogenesis in chronic kidney disease.
    Palzkill VR; Tan J; Yang Q; Morcos J; Laitano O; Ryan TE
    Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H44-H60. PubMed ID: 37921663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
    Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
    Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.
    Salminen A
    J Mol Med (Berl); 2023 Mar; 101(3):201-222. PubMed ID: 36757399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Aryl Hydrocarbon Receptor in Muscle Exacerbates Ischemic Pathology in Chronic Kidney Disease.
    Balestrieri N; Palzkill V; Pass C; Tan J; Salyers ZR; Moparthy C; Murillo A; Kim K; Thome T; Yang Q; O'Malley KA; Berceli SA; Yue F; Scali ST; Ferreira LF; Ryan TE
    Circ Res; 2023 Jul; 133(2):158-176. PubMed ID: 37325935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis.
    Shyu JF; Liu WC; Zheng CM; Fang TC; Hou YC; Chang CT; Liao TY; Chen YC; Lu KC
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD.
    Walker JA; Richards S; Whelan SA; Yoo SB; Russell TL; Arinze N; Lotfollahzadeh S; Napoleon MA; Belghasem M; Lee N; Dember LM; Ravid K; Chitalia VC
    J Am Soc Nephrol; 2021 Nov; 32(11):2834-2850. PubMed ID: 34716244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
    Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
    Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
    Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
    J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy.
    Lu W; Cheng S; Xu J; Xiao Z; Yu Y; Xie Q; Fang Y; Chen R; Shen B; Xie Y; Ding X
    Toxicol Lett; 2024 May; 396():81-93. PubMed ID: 38670245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Insights into the Interaction of Tryptophan Metabolites with the Human Aryl Hydrocarbon Receptor
    Badawy AA; Dawood S
    Front Biosci (Landmark Ed); 2024 Sep; 29(9):333. PubMed ID: 39344334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal Tryptophan Supplementation Protects Adult Rat Offspring against Hypertension Programmed by Maternal Chronic Kidney Disease: Implication of Tryptophan-Metabolizing Microbiome and Aryl Hydrocarbon Receptor.
    Hsu CN; Lin IC; Yu HR; Huang LT; Tiao MM; Tain YL
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease.
    Walker JA; Richards S; Belghasem ME; Arinze N; Yoo SB; Tashjian JY; Whelan SA; Lee N; Kolachalama VB; Francis J; Ravid K; Sherr D; Chitalia VC
    Kidney Int; 2020 Mar; 97(3):538-550. PubMed ID: 31932072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation.
    Liu JR; Miao H; Deng DQ; Vaziri ND; Li P; Zhao YY
    Cell Mol Life Sci; 2021 Feb; 78(3):909-922. PubMed ID: 32965514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.